Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04305886 · ClinicalTrials.gov registry record · NA

Interprofessional Group Intervention to Promote Faculty Wellbeing and Engagement

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
25
Enrollment target

NCT04305886: Completed NA study, sponsored by Massachusetts General Hospital.

NCT04305886 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04305886, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

A randomized trial of an interprofessional intervention to reduce burnout and enhance professional engagement in physicians, certified nurse midwives, and nurse practitioners.

Primary Outcome

Change from baseline in 2 item Maslach Burnout Inventory scores before and after the intervention. Minimum score: 2; Maximum score: 14 Higher score = more burnt out (worse outcome)

Interventions

  • OTHER Discussion Guide

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2018-05-01
Est. Completion 2018-09-30
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT04305886 record still lists

NCT04305886 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Discussion Guide is the first listed.

NCT04305886 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04305886 about?

NCT04305886 is a clinical study titled "Interprofessional Group Intervention to Promote Faculty Wellbeing and Engagement". A randomized trial of an interprofessional intervention to reduce burnout and enhance professional engagement in physicians, certified nurse midwives, and nurse practitioners.

What is the current status of trial NCT04305886?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2018-05-01. Estimated completion is 2018-09-30.

What interventions are being tested in trial NCT04305886?

The interventions under investigation include: Discussion Guide (OTHER).

Who is sponsoring clinical trial NCT04305886?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04305886's enrollment target sits among peer trials

25 1712th of 2000 higher than 265 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04305886, the US trial registry maintained by the National Library of Medicine. NCT04305886 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.